Presentation is loading. Please wait.

Presentation is loading. Please wait.

A. Bryskier  Clinical Microbiology and Infection 

Similar presentations


Presentation on theme: "A. Bryskier  Clinical Microbiology and Infection "— Presentation transcript:

1 Perfecting the ring and extending the antibacterial spectrum: ‘the multiple generations’ 
A. Bryskier  Clinical Microbiology and Infection  Volume 6, Pages (January 2000) DOI: /j tb02035.x Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

2 Figure 1 Discovery of cephalosporin C.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

3 Figure 2 Cephems: classification 2, chemical classification 1, modification of the ring. Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

4 Figure 3 Cephems: classification 3, chemical classification 2, modification of substituents. Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

5 Figure 4 Successive waves of cephems.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

6 Figure 5 Cephems: microbiological classification.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

7 Figure 6 Cephems: pharmacokinetics classification.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

8 Figure 7 Cephems: classification: five subgroups A–E.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

9 Figure 8 Cephems group III.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

10 Figure 9 Cephem group III.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

11 Figure 10 Group III B cephems with long apparent elimination half-life. Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

12 Figure 11 Cephems: group III; Oxa-1-cephems.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

13 Figure 12 Cephems zwitterionic compounds.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

14 Figure 13 Cephems: group IV (2) classification.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

15 Figure 14 Group IV C-3′ ammonium quaternary cephems.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

16 Figure 15 Cephems group IV: chemical alteration.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

17 Figure 16 Cephems: group V (2): classification
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

18 Figure 17 Cephems: group V.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

19 Figure 18 Cephems: group VII: cephems designed for anti-MRSA activity.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions


Download ppt "A. Bryskier  Clinical Microbiology and Infection "

Similar presentations


Ads by Google